According to the researchers, India’s Covaxin activates key memory components of the human immune system that can continue to protect recipients from severe Covid-19 even after...
Medical journal Lancet has now stated that the made-in-India vaccine is 77.8 per cent effective against symptomatic Covid, as demonstrated by the phase 3 data. This...
On Tuesday, World Health Organisation technical advisory group was reviewing data on India’s Covaxin shot against Covid-19 with a decision on its emergency use listing likely soon,...
The Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech’s Covaxin for children in the 2-18 years age group. In September,...
According to sources and reports, the World Health Organization (WHO) has further delayed the emergency use authorisation (EUA) for Covaxin, as the global body has sent more...
On October 5, the Strategic Advisory Group of Experts on Immunization (SAGE) will meet at the World Health Organisation (WHO) to discuss granting the emergency use...
Antibodies in Covaxin recipients decline after 2-3 months for those who got Covishield? Well, you heard it right! A recent study led by ICMR-regional medical research...
The DCGI (Drugs Controller General of India) has approved for a study on mixing of Covaxin and Covishield vaccines in India. On July 29, a Subject Expert...
The Pune-based National Institute of Virology (NIV) conducted a study on 18 people, who inadvertently received both Covishield and Covaxin doses in Uttar Pradhesh’s Siddharth Nagar....
In a statement, Bharat Biotech claimed that the Covaxin is overall 77.8 per cent effective against Covid, citing the data from the third phase of clinical...
Recent Comments